Resultats de la cerca - Huitema, Alwin D R

Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels per Groenland, Stefanie L., Katz, Daniela, Huitema, Alwin D. R., Steeghs, Neeltje

Obtenir text complet Obtenir text complet Obtenir text complet

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] per Hendrikx, Jeroen J M A, Beijnen, Jos H, Huitema, Alwin D R

Obtenir text complet Obtenir text complet Obtenir text complet

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components per Bastida, Carla, Soy, Dolors, Ruiz‐Esquide, Virginia, Sanmartí, Raimon, Huitema, Alwin D.R.

Obtenir text complet Obtenir text complet Obtenir text complet

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis per Dorlo, Thomas P. C., Huitema, Alwin D. R., Beijnen, Jos H., de Vries, Peter J.

Obtenir text complet Obtenir text complet Obtenir text complet

Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice per Simeoli, Raffaele, Dorlo, Thomas P. C., Hanff, Lidwien M., Huitema, Alwin D. R., Dreesen, Erwin

Obtenir text complet Obtenir text complet Obtenir text complet

Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses per Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Obtenir text complet Obtenir text complet Obtenir text complet

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152) per Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Obtenir text complet Obtenir text complet Obtenir text complet

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia per Boerlage, Thomas C. C., van Hees, Charlotte L. E., Huitema, Alwin D. R., Lauw, Fanny N.

Obtenir text complet Obtenir text complet Obtenir text complet

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing per Verheijen, Remy B., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R., Steeghs, Neeltje

Obtenir text complet Obtenir text complet Obtenir text complet

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes per van Eijk, Maarten, Boosman, René J., Schinkel, Alfred H., Huitema, Alwin D. R., Beijnen, Jos H.

Obtenir text complet Obtenir text complet Obtenir text complet

Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MS per de Jong, Karen A.M., Rosing, Hilde, Vermunt, Marit, Huitema, Alwin D.R., Beijnen, Jos H.

Obtenir text complet Obtenir text complet Obtenir text complet

Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review per Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Obtenir text complet Obtenir text complet Obtenir text complet

Correction to: Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review per Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Obtenir text complet Obtenir text complet Obtenir text complet

Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin per Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R

Obtenir text complet Obtenir text complet Obtenir text complet

Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′‐difluorodeoxyuridine and their nucleotides per Derissen, Ellen J. B., Huitema, Alwin D. R., Rosing, Hilde, Schellens, Jan H. M., Beijnen, Jos H.

Obtenir text complet Obtenir text complet Obtenir text complet

Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model per ter Heine, Rob, Kane, Sean P., Huitema, Alwin D.R., Krasowski, Matthew D., van Maarseveen, Erik M.

Obtenir text complet Obtenir text complet Obtenir text complet

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs per Molenaar-Kuijsten, Laura, Van Balen, Dorieke E. M., Beijnen, Jos H., Steeghs, Neeltje, Huitema, Alwin D. R.

Obtenir text complet Obtenir text complet Obtenir text complet

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa per Ekhart, Corine, Doodeman, Valerie D, Rodenhuis, Sjoerd, Smits, Paul H M, Beijnen, Jos H, Huitema, Alwin D R

Obtenir text complet Obtenir text complet Obtenir text complet

Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents per Zandvliet, Anthe S., Karlsson, Mats O., Schellens, Jan H. M., Copalu, William, Beijnen, Jos H., Huitema, Alwin D. R.

Obtenir text complet Obtenir text complet Obtenir text complet

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer per Koolen, Stijn L W, Oostendorp, Roos L, Beijnen, Jos H, Schellens, Jan H M, Huitema, Alwin D R

Obtenir text complet Obtenir text complet Obtenir text complet